Lung Cancer Surgery Market to Reach US$ 20.2 Bn by End of 2031: TMR Study

An increase in adoption of customized medicines for therapeutic and diagnostic purposes are projected to serve as an industry trend during the forecast period

Wilmington, Delaware, United States,, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc.The global Lung Cancer Surgery Market is likely to expand at a CAGR of 5.6% between 2023 and 2031. The increase in cases of lung cancer worldwide is projected to increase the number of lung cancer surgeries performed during the forecast period. The introduction of advanced technologies such as robotic surgery and video-assisted thoracoscopic surgery (VATS) in cancer treatment is expected to promote the growth of the global lung cancer surgery market in the long run.

A rise in awareness and an increase in the popularity of minimally invasive surgeries is anticipated to boost market development for lung cancer surgery. Minimally invasive surgeries not only make cancer treatment more bearable and less painful but also reduces the overall hospital stay and improve patient outcomes. These aspects of lung cancer surgeries are likely to boost business growth during the forecast period.

According to the TMR report, the global lung cancer surgery market value is likely to reach US$ 20.2 Bn by the end of 2031. The rise in global cases of lung cancer is a prime growth driver boosting the need for lung cancer surgery

Request to Sample PDF of this Strategic Report (Use Corporate Mail ID for Top Priority):

Key Findings of Study

  • Advances in Surgical Techniques: Major technological advancements in new surgical techniques such as minimally invasive surgeries have gained traction with their success rates in the past couple of years. Such advancements in surgical technology and procedures are likely to help create lucrative business opportunities for the global lung cancer surgery market during the forecast period. Besides this, innovations in surgical treatment for cancer offers added advantages such as lesser complications, less pain, and better results as compared to the traditional surgical procedures. These factors are anticipated to help promote industry growth during the forecast period.
  • Advent of 3D-printed Models for Surgeries: The use of 3D printed models for surgical procedures has been beneficial for lung cancer surgeries. Minimally invasive surgeries offer robot-assisted thoracic surgery and video-assisted thoracoscopic surgery (VATS), which have lessened the invasiveness of lung cancer surgeries, thereby resulting in faster patient recovery. Therefore, the increase in adoption of 3-D printed models for surgical procedures is likely to aid in market expansion in the next few years.

Key Drivers

  • Rise in prevalence of lung cancer cases is expected to boost demand for surgery, thus, driving market growth
  • Increase in adoption of minimally invasive techniques for cancer treatment is anticipated to promote market development
  • High success rate of lobectomy procedures for cancer treatment is projected to help increase market size

Buy this Premium Research Report | Immediate Delivery Available-

Regional Growth Dynamics

  • North America is anticipated to account for dominant share in the global lung cancer surgery market. Substantial patient pool and availability of better therapeutic and surgical approaches are major factors driving the dominance of the region.
  • The rise in cases of lung cancer in Canada and the United States are projected to augment the need for surgical treatment options for patients. This, along with the presence of high-income population and favorable medical reimbursement policies are likely to help North America continue dominating the overall market in the coming years.
  • Asia Pacific is expected to emerge as the fastest growing market for lung cancer surgery during the forecast period. This can be ascribed to the presence of a high smokers’ population and the establishment of better medical infrastructure and facilities in emerging nations of the region.

Key Players

Prominent players in the global lung cancer surgery market include

  • Ethicon (Johnson & Johnson Services Inc.),
  • Intuitive Surgical,
  • Olympus Corporation,
  • Accuray Incorporated,
  • Siemens Healthineers, and Medtronic.

Ask for References:

Lung Cancer Surgery Market Segmentation


  • Lobectomy
  • Segmentectomy
  • Wedge Resection
  • Pneumonectomy


  • Thoracotomy
  • Minimally Invasive Surgery


  • Hospitals
  • Ambulatory Surgical Centers
  • Others


  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America


  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Japan
  • China
  • India
  • GCC Countries
  • South Africa
  • Brazil
  • Mexico

Related Healthcare Reports

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Nikhil Sawlani
Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453